Zyflo Tablet
Product Images NDC 10122-901
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zyflo (NDC 10122-901). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Chiesi Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Mean Change From Baseline To End Of Study (Zyflo 2)
This is a table showing the mean change in different variables for a six-month study of ZYFLO 600 mg. The variables include Trough FEV (L), AM PEFR (Limin), PM PEFR (Limin), i-Agonist Use (pufs/day), Daily Symptom Score (0-3 Scale), and Nocturmal Symptom Score (0-3 Scale). The table provides specific values for each variable, which are the changes observed from baseline to the end of the study.*
Mean Change From Baseline To Trough Fev1 (l) (Zyflo 3)
Proportion Of Patients Experiencing Adverse Events In Placebo-controlled Studies In Asthma (Zyflo 4)
Table 2 shows the proportion of patients who experienced adverse events in placebo-controlled studies for asthma using ZYFLO 600ms. The table lists different body systems and events, such as headache, pain, abdominal pain, dyspepsia, and myalgia. The table also shows the occurrence of these events in both the treatment group (ZYFLO 600ms) and the placebo group. There is some error in the text, as some of the characters are unreadable or appear to be randomly placed.*
Zyflo Bottle (Zyflo 5)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.